Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Lieven Baert"'
Autor:
Katie Amssoms, Philip A Born, Max Beugeling, Ben De Clerck, Ellen Van Gulck, Wouter L J Hinrichs, Henderik W Frijlink, Niels Grasmeijer, Guenter Kraus, Roger Sutmuller, Kenny Simmen, Lieven Baert
Publikováno v:
PLoS ONE, Vol 13, Iss 8, p e0202961 (2018)
A single-injection vaccine formulation that provides for both a prime and a boost immunization would have various advantages over a multiple-injection regime. For such a vaccine formulation, it is essential that the booster dose is released after a c
Externí odkaz:
https://doaj.org/article/39d9cf7d09974343b19898981fbcf509
Autor:
Max Beugeling, Katie Amssoms, Freek Cox, Ben De Clerck, Ellen Van Gulck, Jeroen A. Verwoerd, Guenter Kraus, Dirk Roymans, Lieven Baert, Henderik W. Frijlink, Wouter L. J. Hinrichs
Publikováno v:
Pharmaceutics, Vol 11, Iss 10, p 510 (2019)
Currently, there is an increasing interest to apply pre-fusion (pre-F) protein of respiratory syncytial virus (RSV) as antigen for the development of a subunit vaccine. A pre-F-containing powder would increase the flexibility regarding the route of a
Externí odkaz:
https://doaj.org/article/1fab9f6aa5144ad296de6c6ca8e08c85
Autor:
Lieven Baert, Gabriele Grasso, Caroline Sainvitu, Ingrid Lepot, Marinus J. van Enkhuizen, Karel Lammers, Nicholas Bown
Publikováno v:
Volume 10D: Turbomachinery — Multidisciplinary Design Approaches, Optimization, and Uncertainty Quantification; Turbomachinery General Interest; Unsteady Flows in Turbomachinery.
Whereas the market-share for propeller-driven aircraft is expected to rise to 30–40% of Europe’s regional aviation segment, a significant reduction in perceived noise levels remains a critical challenge for the success of further turboprop deploy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d8bc3006d07ca90f1ccaad5728baf04
https://doi.org/10.1115/gt2022-77969
https://doi.org/10.1115/gt2022-77969
Autor:
Caroline Sainvitu, Ingrid Lepot, Emmanuel Chérière, Vincent Leonardon, Arnaud Nouvellon, Lieven Baert
Publikováno v:
Journal of Turbomachinery. 142
Further improvement of state-of-the-art Low Pressure (LP) turbines has become progressively more challenging. LP design is more than ever confronted to the need to further integrate complex models and to shift from single component design to the desi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4fe6c1cef015485148f33205e7d2712
https://doi.org/10.1115/1.4046232
https://doi.org/10.1115/1.4046232
Autor:
Philip A. Born, Max Beugeling, Kevin Schwengle, Katie Amssoms, Renée S. van der Kooij, Henderik W. Frijlink, Wouter L. J. Hinrichs, Lieven Baert, Merel van der Meulen, Niels Grasmeijer
Publikováno v:
International Journal of Pharmaceutics, 551(1-2), 195-202. Elsevier Bedrijfsinformatie b.v.
AAPS PharmSci 360
University of Groningen
AAPS PharmSci 360
University of Groningen
Successful immunization often requires a primer, and after a certain lag time, a booster administration of the antigen. To improve the vaccinees' comfort and compliance, a single-injection vaccine formulation with a biphasic pulsatile release would b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f2f7c33a812b50b73bbdfdc3b0ce49d
https://research.rug.nl/en/publications/e8f5a553-8b3d-49e0-a618-cfd3d2718396
https://research.rug.nl/en/publications/e8f5a553-8b3d-49e0-a618-cfd3d2718396
Autor:
Guenter Kraus, Jeroen A. Verwoerd, Katie Amssoms, Ben De Clerck, Henderik W. Frijlink, Wouter L. J. Hinrichs, Lieven Baert, Ellen Van Gulck, Max Beugeling, Dirk Roymans, Freek Cox
Publikováno v:
Pharmaceutics
Pharmaceutics, 11(10):510. MDPI AG
Volume 11
Issue 10
Pharmaceutics, Vol 11, Iss 10, p 510 (2019)
Pharmaceutics, 11(10):510. MDPI AG
Volume 11
Issue 10
Pharmaceutics, Vol 11, Iss 10, p 510 (2019)
Currently, there is an increasing interest to apply pre-fusion (pre-F) protein of respiratory syncytial virus (RSV) as antigen for the development of a subunit vaccine. A pre-F-containing powder would increase the flexibility regarding the route of a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4722e37b0ac7749f596d705f589f8903
https://pubmed.ncbi.nlm.nih.gov/31623333
https://pubmed.ncbi.nlm.nih.gov/31623333
Publikováno v:
Volume 2D: Turbomachinery.
Turbomachinery design has become a simulation-driven process, permanently confronted to the dual need to reduce the cycle time and to further integrate complexity and multiple physics. This duality pushes towards high-dimensional design spaces and fa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6cbfcf1b97d301951dcf616744264f5
https://doi.org/10.1115/gt2018-76639
https://doi.org/10.1115/gt2018-76639
Publikováno v:
Volume 2C: Turbomachinery.
Turbomachinery components are designed to achieve high performances while being exposed to a complex flow environment with varying operating conditions. Whereas the purpose of a new design optimisation is straightforward — obtaining a better design
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::709f19f143f12080e8fc3f4f5e64b254
https://doi.org/10.1115/gt2017-64610
https://doi.org/10.1115/gt2017-64610
Publikováno v:
Chromatographia. 73:439-445
A liquid chromatographic method with UV detection was developed for the assay of a tablet for HIV (human immunodeficiency virus) treatment containing three active components, which are emtricitabine, tenofovir disoproxil fumarate and rilpivirine. A H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65eda104a22599e2ee8f0d107301defc
https://doi.org/10.1007/s10337-010-1906-1
https://doi.org/10.1007/s10337-010-1906-1
Autor:
Guy Van den Mooter, Liesbeth Grooten, Gerben Albert Eleutherius Van 'T Klooster, Elke Van Gyseghem, Jan Rosier, Laurent Schueller, Herman de Kock, Marie-Claude Rouan, Lieven Baert, Voorspoels Jody Firmin Marceline, Pieter Van Remoortere
Publikováno v:
European Journal of Pharmaceutical Sciences. 41:193-200
Various formulations for combination of the anti-HIV protease inhibitor darunavir (DRV) and TMC41629, a pharmacokinetic booster for DRV, were studied. TMC41629 (a BCS-IV compound) was formulated in capsules, as polyethylene glycol 400 (PEG400) soluti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0e4035aa15a1d25e1f567c11c129df2
https://doi.org/10.1016/j.ejps.2010.05.017
https://doi.org/10.1016/j.ejps.2010.05.017